NexgenRx Inc. (TSXV:NXG)
Canada flag Canada · Delayed Price · Currency is CAD
0.3600
0.00 (0.00%)
Apr 9, 2026, 4:00 PM EST

NexgenRx Cash Flow Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1.290.61-0.33-0.024.02
Depreciation & Amortization
1.221.271.311.411.33
Stock-Based Compensation
0.010.020.040.060.1
Other Adjustments
0.790.390.040.2-2.06
Change in Receivables
0.19-0.04-0.470.07-0.12
Changes in Accounts Payable
1.47-0.680.26-0.490.54
Changes in Other Operating Activities
0.01-0.420.44-0.160.01
Operating Cash Flow
4.981.151.281.073.82
Operating Cash Flow Growth
332.60%-9.95%19.82%-72.13%44.16%
Capital Expenditures
-0.3-0.09-0.08-0.39-0.13
Sale of Property, Plant & Equipment
0.03----
Purchases of Intangible Assets
-0.05-0.23-0.17-0.12-1.24
Purchases of Investments
-0.18-0.18---
Investing Cash Flow
-0.5-0.5-0.25-0.51-1.37
Long-Term Debt Repaid
-----0.51
Net Long-Term Debt Issued (Repaid)
-----0.51
Issuance of Common Stock
-0.190.06--
Net Common Stock Issued (Repurchased)
-0.190.06--
Common Dividends Paid
-1.07-0.71-0.7-0.7-
Preferred Share Dividends Paid
-0.23-0.2-0.2-0.2-0.13
Other Financing Activities
-0.11-0.1-0.08-0.21-0.3
Financing Cash Flow
-1.41-0.82-0.92-1.11-0.94
Net Cash Flow
3.07-0.170.11-0.551.52
Free Cash Flow
4.681.061.20.683.7
Free Cash Flow Growth
339.62%-11.31%77.23%-81.69%46.03%
FCF Margin
26.10%6.46%8.67%5.30%31.23%
Free Cash Flow Per Share
0.060.010.020.010.05
Levered Free Cash Flow
3.70.71.590.345.27
Unlevered Free Cash Flow
3.710.711.630.345.89
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.